Xray & CT Technologist
About the job
- Perform and maintain daily CT scanner check-ups and quality control as required by credentialing organizations.
- Perform daily quality assurance of the CT schedule to address potential conflicts.
- Handle the non-technical protocol process, including confirming patient preparation, blood work, allergies and contraindications; monitoring missing requisitions; requesting missing requisitions from referring physician offices; verifying requisition details and authorization numbers; ensuring the requested exam matches the order; confirming the correct site, time slot and day; and coordinating scheduling changes with the Customer Care Center.
- Review requisitions to determine the proper study; interview patients for medical history; prepare patients for exams; administer oral and intravenous contrast; use a creatinine meter; explain contrast benefits and risks; position patients; select scan parameters and exposure factors; monitor patients during scans; review images for quality and abnormalities; follow Occupational Safety and Health Administration guidelines and radiation protection and recordkeeping requirements; complete documentation and file notations; perform protocol-based quality control and patient tests; perform weekly emergency crash cart quality control; and work cooperatively with the radiologist.
- Provide patient care and service by explaining exams, contrast and positioning; demonstrate proficient intravenous skills; explain procedures to reduce anxiety and obtain cooperation; track patients from exam start through discharge; ensure stat exams are processed promptly; and assess emergency situations and assist the radiologist with medicines or supplies as needed.
- Perform intravenous insertion as needed in accordance with Occupational Safety and Health Administration guidelines.
- Perform computerized tomography to demonstrate anatomy for interpretation or intervention at the request of a licensed practitioner.
- Perform advanced examinations as required by location, which may include CT angiography, cardiac CT and CT colonography.
About the company
Radiology Partners operates a physician-led radiology practice in the United States, partnering with hospitals, imaging centers, and clinics to manage radiology services. It earns revenue mainly through fee-for-service arrangements for diagnostic and interventional radiology and teleradiology, while providing clinical leadership and back-office support to its partner facilities. The company uses MosaicOS, an AI-enabled cloud-native operating system, to automate reporting and optimize workflows, and it offers 24/7 subspecialty radiology coverage across its network. Its goal is to expand access to high-quality radiology by combining physician ownership with a large nationwide network and robust partner support.
Company Size
1,001-5,000
Company Stage
Debt Financing
Total Funding
$4.6B
Headquarters
El Segundo, California
Founded
2012
Get referred to Radiology Partners
See people who can refer or advise you
Simplify's Take
What believers are saying
- RP closed $720 million growth equity and refinanced debt on July 1, 2025.
- Mosaic Reporting launched June 2026 and already deploys across thousands of radiologists.
- DataFirst named RP exclusive migration partner in December 2025, supporting large-scale integrations.
What critics are saying
- UnitedHealthcare and Aetna sued RP in 2025-2026 over No Surprises Act billing tactics.
- If courts curtail arbitration winnings, out-of-network revenue drops fast and leverage tightens.
- Everlight integration still needs approvals; execution slip delays synergies and distracts management.
What makes Radiology Partners unique
- Radiology Partners launched MosaicOS on June 9, 2026, embedding AI into reporting workflows.
- Everlight acquisition on August 25, 2026 creates a global teleradiology network across five countries.
- RP serves 3,400-plus facilities, giving national scale and subspecialty coverage competitors cannot match.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Remote Work Options
Flexible Work Hours
Paid Vacation
Paid Holidays
Family Planning Benefits
Wellness Program
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%FDA funds study on LLMs evaluating AI radiology reports. Cognita Imaging has won a $1.29 million agreement with the FDA to examine whether large language models can accurately assess AI-generated radiology reports. The 18-month study, which began June 22, targets a major hurdle in AI oversight: evaluating systems that produce open-ended text rather than simple diagnostic indicators. Current FDA-approved radiology AI tools handle specific tasks - such as identifying blood clots in CT scans or lung collapses in X-rays - making their assessment relatively simple. However, newer platforms, including those developed by Cognita, generate complete radiology reports containing hundreds of potential findings. This complexity renders traditional radiologist reviews impractical for large-scale use. The project will employ a panel of multiple LLMs to evaluate AI-generated reports against a dataset of 1 million patient exams collected from various U.S. healthcare settings. Performance will be measured across patient demographics, clinical environments, and imaging equipment types, including rare conditions. When the LLMs disagree on significant clinical issues, human radiologists will intervene to determine whether errors originate from the original AI, the LLM panel, or the baseline report. Akshay Chaudhari, Cognita's co-founder and a Stanford radiology associate professor, stated the initiative will quantify two primary risks in generative AI: hallucinations, plausible but incorrect information, and omissions of critical details. The aim is to assess whether these errors hold clinical significance and how frequently they appear. The final deliverables will include a full report for the FDA, along with open-source software code, guidelines for constructing LLM review panels, and comparisons between large and smaller validation datasets. Chaudhari stressed that the findings should provide a framework for future AI regulations, ensuring the approach remains adaptable beyond Cognita's own products. The FDA's increasing focus on AI regulation is evident in other recent actions. Earlier this year, Cognita received a breakthrough device designation for a vision-language model designed to interpret chest X-rays and produce draft radiology reports for physician review. This designation, granted separately from the research contract, reflects the agency's commitment to accelerating approvals for tools addressing critical clinical needs. Chaudhari noted that while the study plan for this model remains under development, the FDA's partnerships have clarified regulatory pathways. A separate FDA discussion paper on generative AI highlights broader efforts to establish standardized evaluation methods. The shift toward LLM-based review systems could reduce dependence on radiologist-led panels, which are slow and struggle to keep up with AI advancements. Yet challenges remain: if LLMs introduce biases or inaccuracies, the system's reliability depends on human oversight at key decision points. Founded in 2024 and acquired by Radiology Partners, the largest U.S. radiology group, just one year later, Cognita has drawn on insights from radiologists in both academic and community practices. Real-world pressures, such as radiologist shortages and mounting backlog cases, highlight why AI tools capable of automating report generation could address pressing workforce gaps. Chaudhari framed the project's success as dependent on proving that LLM juries can consistently match or improve upon traditional review methods without creating new risks. Seraphina Wentworth
Radiology Partners (RP) completed a series of previously announced financing transactions. As a part of these actions, RP closed a growth equity investment of approximately $720 million, completed an exchange offer with respect to its existing notes and finalized an amendment to its outstanding credit facilities.
Agellus-Backed HighGrove Acquires O&A Landscaping. HighGrove Partners, an Atlanta-based commercial landscaping company backed by Agellus Capital, completed its acquisition of O&A Landscaping, which is headquartered in the Greater Orlando, Fla. area. The acquisition expands HighGrove's presence in Florida, a key market in the company's broader southeast growth strategy. Founded in 2006 by Carl Osborn and Rob Allis, O&A provides landscape maintenance, enhancement, arbor care and irrigation services to a broad client base throughout Central Florida. The company has operated in the region for nearly two decades, building its business around commercial landscaping and related property services. Radiology Partners Buys Everlight Radiology from Livingbridge Everlight is an international teleradiology provider serving hospitals, health systems and imaging centers. To read the entire story, you must be logged in. Escalade Purchases ASL Solutions Assets, Expanding into Pet Products ASL Solutions is an Illinois-based manufacturer of premium insulated dog and cat houses. To read the entire story, you must be logged in. Quad-C's Flow Service Partners Acquires Altman Air Conditioning The acquisition expands Flow's operations in Florida and complements Cortez, an existing Flow company serving commercial customers across the state. To read the entire story, you must be logged in. Accenture Buys Dutch SAP Consultancy McCoy McCoy is a Dutch SAP transformation partner focused on mid-market companies. To read the entire story, you must be logged in.
Radiology Partners, the leading provider of technology and AI-enabled radiology services in the US, has entered into a definitive agreement to acquire Everlight Radiology, a leading international teleradiology provider. Financial terms were not disclosed. Everlight serves hospitals, health systems and imaging centres across the UK, Ireland, Australia, New Zealand and South Africa. The company operates a "follow-the-sun" model with a network of more than 800 radiologists working in over 40 countries, reporting over 2.5 million exams annually for 340-plus client organisations. The combination will create a global leader in teleradiology, bringing together Everlight's international network with Radiology Partners' vRad unit, the largest teleradiology platform in the US. The transaction is subject to customary regulatory approvals and closing conditions.
Radiology Partners has appointed Matt Peterson as President of RP Clinical Services, effective 20 July. Peterson joins from Universal Health Services, where he led the Behavioral Health Division overseeing more than 350 facilities across 39 US states and internationally. Krishna Nallamshetty, MD, transitions from Interim Chief Operating Officer to full-time COO, whilst also serving as Interim Chief Medical Officer during the search for a permanent CMO. Dr Nallamshetty previously served as Chief Medical Officer of Radiology Partners and Practice President of Radiology Associates of Florida. The appointments aim to strengthen RP Clinical Services' leadership by combining Peterson's healthcare operating experience with Dr Nallamshetty's clinical and operational expertise. Both will report to Rich Whitney, Chairman and CEO of Radiology Partners.